INVESTOR PRESENTATION Summer/Fall 2024

CATEGORIES OF MODULES 9:41 8:387 < Sponsored Doxiera all Pl ....? 9:41 AM 100% Hello from Marsha Lawrence, MD Lawrence Miller, MD To: me Inboxx 2/24/17, 11:02 AM DAGAV Massachusetts General Hospital suggested Sponsored New ALS Center Aims to Change the Field Mass General is spearheading a revolutionary new approach to amyotrophic lateral sclerosis (ALS) 25 32 Comments 市 Add a comment Op-Med This is important safety info with a link Sponsored by PharmaCo View head-to-head trial data for Doxlera® (doxilimumab) In a 52-week study of patients with chronic obstructive pulmonary disease (COPD), once daily Doxlera® (doxilimumab) inhalation mist significantly reduced the rate of moderate-to- severe COPD exacerbations (flare-ups) and delayed time to first exacerbation vs nosazone." Significant Reduction in Rate of COPD Exacerbations With Doxlera® Annual Rate of COPD Exacerbations 1.26 35% Reduction 0.82 Contact your local rep for more info: A Daniel Jacobson Houston, TX a Home Search Dialer Fax/Msg Careers Home Search Dialer Fax/Msg Dear Dr. Miller, I would like to introduce myself as a cerebrovascular neurosurgeon here at University Medical Center. If our team can help one of your patients, please let me know. I specialize in the surgical treatment of cerebral aneurysms, carotid artery stenosis, intracerebral hemorr- hage, arteriovenous malformations and dural arteriovenous fistulas. We're offering a new surgical approach to correct visible defects in the skull after prior injury or previous craniotomy with minimized risk to the patient. The new technique, called pericranial-onlay cranioplasty, addresses most complex challenges in cranial res- toration by navigating the structures of the skin, subcutaneous layers, skull and dura to restore any calvarial bone by attaching either the original piece of the skull or a custom-contoured implant. I would love to connect on Doximity. If you're interested in learning more about this new cranioplasty technique or if you would like to discuss a patient, please don't hesitate to call me on my mobile at (346) 245-3945. Sincerely, Marsha Lawrence, MD Chair, Neurosurgery Medical Director, Neurosciences Institute at University Medical Center Accept Invitation doximity Awareness Build brand equity and communicate key messages Interactivity Replace face-to-face interactions with digital alternatives Peer Connect and build professional relationships Proprietary 10 10

View entire presentation